On July 15, 2009, NIDA's Deputy Director, Dr. Timothy Condon, CTN Director, Dr. Betty Tai, and John Hamilton, CEO of Regional Network of Programs co-chaired a meeting titled: Program Response to Patient Relapse. This event provided the opportunity to discuss current treatment policies on relapse; learn more about how the drug abuse and addiction field views and responds to patient relapse across various treatment settings; and provided guidance to NIDA regarding how research and treatment approaches can best serve addicted patients who relapse. This meeting was organized by Drs. Denise Pintello (OD), Harold Perl (CCTN) and Petra Jacobs (CCTN).
Drs. Roger Sorensen, Susan Volman and Da-Yu Wu, DBNBR, organized a workshop entitled: "Sensory Coding in Drug Abuse", that was held on June 9, 2009 in Bethesda, MD. The goal of the Workshop was to bring together drug abuse and non-drug abuse researchers to discuss the current state of knowledge for processing environmental information within sensory system, especially as relevant to the recognition and awareness of drug-related cues that may trigger thoughts of drug seeking and relapse after prolonged abstinence to drug use, and to identify potential future areas of research on brain processing of drug-related sensory cues.
Drs. William A. Corrigall and David Shurtleff, Director, DBNBR, organized and co chaired a symposium entitled: "Nicotinic Cholinergic Mechanisms in Drug Dependence: Receptor Subtypes and Ligands" at the annual meeting of the College of Drug Dependence on June 25, 2009. This symposium described novel aspects of nicotinic cholinergic mechanisms at the receptor level. The speakers for this symposium were:Sharon Grady, University of Colorado, Boulder, Boulder, CO; Jon Lindstrom, University of Pennsylvania, Philadelphia, PA; Roger Papke, University of Florida, Gainesville, FL; and Thorgeir Thorgeirsson, deCode, Reykjavik, Iceland.
Drs. Joni Rutter, David Shurtleff, Cheryl Boyce, and Jim Bjork co-chaired a workshop entitled, Not Just a Matter of Gray and White: Exploring the Importance of Evolution, Genes, and Experience on Brain Development on July 9-10, 2009. The main purpose of the meeting was to explore approaches towards understanding the interplay between genes and environment in shaping human brain development. The discussion centered around The National Children's Study (NCS), a longitudinal cohort of 100,000 children to examine the effects of environmental and genetic influences on the health and well-being of children. This study, along with other valuable resources, may provide a comprehensive look into the developing brain by linking genetic variation with brain morphology, and subsequently generating informative biological patterns of normative data for understanding factors related to brain development, as well as to provide a reference for further disease-specific analyses. The goal of this workshop was to explore the possibility of devising a multi-disciplinary large-scale project to examine genetic and brain morphology differences that advance our understanding of brain development.
Drs. Elena Koustova, Minda Lynch, Paul Schnur and David Shurtleff organized and co-chaired a workshop on Validation of in vivo screening for Drug Discovery and Development: Focus on Smoking Cessation, held August 3-4, 2009 at the at the Hilton Washington DC/Rockville. The workshop participants presented and discussed up-to-date knowledge about the mechanisms of nicotine addiction, derived from controlled laboratory studies and from clinical experience with available pharmacotherapies, and provided new approaches and screening tools for medications discovery and development.The goals of the workshop were to: (1) identify individual animal behavioral paradigms that have been proven to have clinical efficacy in smoking cessation; and (2) to evaluate the theoretical and practical justification of a developing a behavioral battery for medications discovery and development in order to significantly improve the predictive validity of in vivo screening.
Drs. Kristen Huntley organized and chaired and Drs. Davis Shurtleff, Belinda Sims, Cheryl Boyce , Harold Perl and Kristen Huntley presented in a symposium entitled "Navigating Change at the NIH/NIDA- Exciting Opportunities in Tight Times" held at the annual meeting of the American Psychological Association on August 7, 2009, Toronto, Canada.
Drs. Paul Schnur and David Shurtleff co-organized and co-chaired a symposium entitled "Drug Addiction and Learning - What are the underlying connections?" held at the annual meeting of the American Psychological Association on August 8, Toronto, Canada. Presenters discussed issues related to the idea that drug addiction is a chronic relapsing disorder in which compulsive drug use dominates and supersedes the pursuit of otherwise rewarding activities. The realignment of motivational priorities – a form of neural plasticity - reflects multiple and varied long-term neuroadaptations. This symposium highlighted the work of scientists who use interdisciplinary approaches to understand the connections between processes of addiction, motivation and learning, homeostatic regulation and their neurobiological substrates. Speakers for this symposium were Dr. Gary Aston-Jones, University of South Carolina College of Medicine; Dr. Colleen McClung, University of Texas South Western Medical center Dallas; Dr. Patricia Grigson, Pennsylvania State University College of Medicine; and Dr. Peter Kalivas University of South Carolina College of Medicine.
Drs Nehal Vadhan and David Shurtleff co-organized and co-chaired a symposium entitled "Using Behavioral and Cognitive Assessments to Inform Addiction Treatment" held at the annual meeting of the American Psychological Association on August 9, 2009, Toronto, Canada. Presenters addressed issues related to the notion that the process of becoming addicted to drugs of abuse involves long-term neuroadaptations in the brain regions that underlie learning and memory consolidation. Moreover, exposure to drugs of abuse may cause epigenetic changes, changes in gene expression, and protein modifications leading to neurobiological changes that may alter cognitive and behavioral abilities such as learning, decision-making, and inhibitory control, as well as motivational processes. The level and severity of alteration in these processes varies among addicted individuals and may not always correlate with frequency of drug use. However, basic laboratory-based procedures are successfully being used to assess and characterize specific cognitive and behavioral alterations in these individuals. Not only can these measures be used to assess specific drug-induced deficits across different cognitive and behavioral domains in drug-addicted individuals, they can assess between-subject individual differences in drug-induced cognitive deficits as well. Importantly, these intermediate phenotypes may serve as valuable predictors of treatment compliance, ability to stay abstinent, and propensity to relapse, and thus may prove to be useful in guiding and selecting treatment interventions for individuals. This symposium highlighted recent research that has successfully targeted these issues. Speakers for the symposium were Rita Z. Goldstein, Ph.D., Brookhaven National Laboratory, Upton, NY; Nehal P Vadhan, PhD Columbia University/NYSPI, New York, NY; Anna E Goudriaan, Ph.D., University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands, Netherlands; and W . Miles Cox, Ph.D., Bangor University, Bangor, England, United Kingdom.
In collaboration with Drs. David Shurtleff and Joni Rutter, DBNBR, Drs. Cheryl Anne Boyce and James Bjork (DCNBR) co-chaired the NIDA sponsored workshop, entitled "Anatomical MRI Scans with the National Children's Study: Exploring Opportunities and Challenges," on July 9-10, 2009, at the Bethesda North Marriot in Bethesda, Maryland. The goal of the workshop was to explore the possibility of developing a multi-disciplinary large-scale project to examine genetic and brain morphology differences that advance our understanding of brain development and provide a comprehensive look into the developing brain by linking genetic variation with brain morphology, generating informative biological patterns of normative data for understanding factors related to brain development, as well as to provide a reference for further disease-specific analyses.
NIDA awarded 30 Director's Travel Awards for the annual meeting of the College on Problems of Drug Dependence (CPDD), June 20-25, 2009, Reno/Sparks, NV. These awards are given to NRSA trainees and fellows, and Diversity Supplement recipients to attend the CPDD meeting and the NIDA Tutorials Workshop. The Tutorials Workshop enlists several T-32 Training Directors to present on a range of topics in drug abuse and addiction research, designed to broaden the perspective of new researchers in the drug abuse field.
NIDA's Women & Sex/Gender Differences Research Program awarded 27 Women & Gender Junior Investigator Travel Awards for the annual meeting of the College on Problems of Drug Dependence (CPDD), June 20-25, 2009 in Reno/Sparks, Nevada. These $750 awards provide travel support to first author junior investigators who make presentations on the topic of women and/or sex/gender differences. These travel awards have been made annually beginning in 1999, and are designed to promote entry of junior investigators into drug abuse research on women and sex/gender differences. A brochure listing all the awardees since 1999 was made available at CPDD. To further promote research in this field, NIDA published a mini-program book, Focus on Women & Sex/Gender Differences, for the CPDD meeting. Excerpted from the CPPD program book, it contains only those program listings related to women and sex/gender differences. It also contains the CPDD abstracts on women and sex/gender differences, information about the Women & Gender Junior Investigator Travel Awardees presentations, announcement of the travel award program for CPDD 2010, and information on current NIDA funding opportunity announcements in this area. These efforts were led by Drs. Cora Lee Wetherington and Samia Noursi who were assisted by Dr. Lynda Erinoff and Dr. Joe Frascella.
Dr. Vishnu Purohit, DBNBR, organized a symposium on Placental Transfer of Therapeutic Drugs, which was held on March 31, 2009, Rockville, Maryland. The following research areas were discussed in the meeting: Transport of Nutrients and Drugs Across the Human Placental Barrier: Role of Transporters (Dr. Vadivel Ganapathy, Medical College of Georgia); and Placental P-Glycoprotein Activity and Gestational Age: Implications for HIV-1 Infected Pregnant Women (Dr. Jashvant Unadkat, University of Washington). Dr. Rao Rapaka, DBNBR, chaired the discussion of the symposium.
Dr. Vishnu Purohit organized a workshop on the Endocannabionoid System and HIV which was held on June 15, 2009, Rockville, Maryland. The following topics were discussed in the meeting by three speakers: Novel Ligands to Modulate the Endocannabinoid System (Dr. Alexandros Makriyannis, Northeastern University); Protective Effects of Cannabinoids on HIV-1 Gp120-Mediated Insult to the Blood Brain Barrier (Dr. Shalom Avraham, Harvard Medical School); and Cannabinoids Prevent Gp120-Induced Damage on Neural Progenitor Cells (Dr. Hava Avraham, Harvard Medical School). In this workshop, opening remarks were presented by Dr. Jacques Normand and the discussion was led by Dr. Rao S. Rapaka.
Dr. Vishnu Purohit and Dr. Rao S. Rapaka organized a symposium on Cannabinoids and Liver Diseases: Molecular Mechanisms and Drug Development at the International Cannabinoid Research Symposium (ICRS) Meeting, St. Charles, Illinois, USA, July 8-11, 2009. The following topics were covered by four speakers: Endocannabinods, the Liver, and Metabolic Syndrome (Dr. George Kunos, NIAAA/NIH); Cannabinoids, Liver Inflammation, and Cancer (Dr. Prakash S. Nagarkatti, University of South Carolina); Endocannabinoids and Hemodynamic Consequences of Liver Cirrhosis (Dr.Sandor Batkai, NIAAA/NIH); The Endocannabionoid System as a Regulator of the Hepatic Wound Healing Process (Dr. Sophie Lotersztajn, INSERM, France). The symposium was opened by Dr. Cecilia Hillard, President, ICRS; introduced by Dr. Vishnu Purohit, NIDA; and chaired by Dr. George Kunos, NIDA, and Dr. Sophie Lotersztajn, INSERM, France.
Drs. Cora Lee Wetherington, Coordinator, Women and Sex/Gender Differences Research Program, and Wendy Lynch (University of Virginia) co-organized and co-chaired the symposium, "Biological Basis of Sex Differences in Drug Abuse: A Translational Perspective," at the annual meeting of the American Psychiatric Association, May 16-21, 2009 in San Francisco, CA. Presenters were Wendy Lynch, Ph.D. (University of Virginia), Jill Becker, Ph.D. (University of Michigan), Karen Berman, M.D. (NIMH), Marc Potenza, M.D., Ph.D. (Yale University School of Medicine), and Larry Cahill, Ph.D. (UC Irvine).
Drs. Cora Lee Wetherington and Jill Becker (University of Michigan) co-organized and co-chaired the symposium, "Preclinical studies of sex differences in response to cocaine in adolescents: Are they different from adults?" at the annual meeting of the College on Problems of Drug Dependence (CPDD), June 20-25, 2009 in Reno/Sparks, Nevada. Speakers were: Wendy Lynch, Ph.D. (University of Virginia); Marilyn Carroll, Ph.D. (University of Minnesota); Sari Izenwasser, Ph.D. (University of Miami Miller School of Medicine); Cynthia Kuhn, Ph.D. (Duke University Medical Center); and Jill Becker, Ph.D. (University of Michigan).
Drs. Cora Lee Wetherington and Sherry McKee (Yale University School of Medicine) co-organized and co-chaired the symposium, "Role of Sex and Stress in Smoking Maintenance and Relapse," at the annual meeting of the American Psychological Association, August 6-9, 2009 in Toronto, Canada. The panel included: Mariella De Biasi, Ph.D. (Baylor College); Sherry A. McKee, Ph.D. (Yale); Sudie Back, Ph.D. (Medical University of South Carolina); Mustafa al'Absi, Ph.D. (University of Minnesota Medical School). Rajita Sinha, Ph.D. (Yale) will be discussing the presentations.
Dr. Allison Hoffman, DBNBR, with Dr. Ruben Baler, OSPC, organized a joint NIDA-ODS symposium entitled "Caffeine: Is the next problem already brewing", July 7-8, 2009.
Dr. Allison Hoffman hosted a webinar entitled "The 2008 Public Health Service Guideline: Treating Tobacco Use and Dependence", presented by Dr. Michael Fiore. This was hosted by the NIDA Nicotine/Tobacco Interest Group, in partnership with the NIH Tobacco and Nicotine Research Interest Group, July 29, 2009.
On June 16, 2009, Dr. Richard Denisco, DESPR, and Dr. Petra Jacobs, CCTN, co-chaired a Prescription Opioids and Pain Workgroup meeting on June 16, 2009 at the Rockville Hilton in conjunction with SAMHSA entitled Cardiac Effects of Opioid Medications – Planning a Research Agenda.
Dr. James Bjork, DCNBR, organized a Cutting Edge Seminar on Connectivity of the Human Brain: Foundations and Alterations in Psychiatric Disorder, which was sponsored by the NIDA Neuroscience Consortium and held on July 15, 2009 in the Neuroscience Center. This well-attended seminar highlighted advances in the use of fMRI to study inter-regional connectivity of the brain and its potential to uncover endophenotypes of psychiatric disease.
Dr. Yu (Woody) Lin, DCNBR, organized a Cutting Edge Symposium on Science in NeuroAIDS Research and their Implications, which was sponsored by the NIDA Neuroscience Consortium and held on September 1, 2009 at the Neuroscience Center. This cutting-edge seminar introduced 1) early biomarkers of compromised neurocognitive capacity in apparently cognitive asymptomatic HIV+ patients who remain medically stable and clinical significance of neural efficacy in daily functioning, resilience and treatment adherence; 2) HIV clade-dependent activation of NMDA receptors and its implications in future mechanistic and clinical studies of neuroAIDS; 3) macrophage delivery of nanoformulated drugs for HIV encephalopathy.
On July 29, 2009, NIDA Clinical Trials Network and NIDCR PEARL Network joint Dental SBIRT Partnership held their first meeting as a group, with participants from NIDA, NIDCR, PEARL Network, CTN nodes, and EMMES, to discuss protocol development for the Dental SBIRT project.
On April 23-24, 2009, the Special Populations Office hosted a two-day Research Development Seminar Series Workshop in Bethesda, Maryland. Chaired by Pamela Goodlow, the workshop was geared to new investigators interested in becoming funded through NIDA and the NIH. During the two-day session, participants met with funded NIDA investigators and senior NIDA program officials, participated in a mock review of submitted draft research grant applications, and learned about the NIH grants submission and review processes.
The Special Populations Office (SPO) provided support for the 2009 Hawai'i Addictions Conference/AAPI Workgroup Scientific Conference May 11-12, 2009 in Honolulu, Hawaii. The Asian American/Pacific Islander (AAPI) Workgroup of the SPO convened this meeting in order to discuss drug abuse and addiction research and treatment issues among Asian Americans and Pacific Islanders. Ana Anders attended this meeting and presented welcome remarks on behalf of the SPO.
On May 11, 2009, the Special Populations Office (SPO) convened a meeting of NIDA grantees participating in the Summer Research with NIDA program. Chaired by Flair Lindsey, the purpose of the meeting was to (1) familiarize investigators/mentors with the program's expectations, (2) provide information on strategies of running an effective mentoring program with students from diverse backgrounds, and (3) provide helpful information on NIH and NSF resources. Additionally, participants had an opportunity to hear from research sites that have had successful summer programs/experiences through the Summer Research with NIDA program.
The Special Populations Office (SPO) and the African American Researchers and Scholars Workgroup (AARSWG) convened a "Mini Medical School" centered on the theme of Marginalized African American Males on July 20, 2009 at the Morehouse School of Medicine in Atlanta, Georgia. The one-day meeting joined health care professionals, researchers, and members of the community interested in understanding the needs of substance abusers and addiction in the African American community. Scientists and physicians lectured on topics that covered the process of addiction, psychopharmacology, addiction treatment and services, issues arising from substance abuse and its research implications, HIV/AIDS and other related co-morbidities. The AARSWG presented an award of exemplary leadership to Ms. Pamela Goodlow, Special Populations Office, and NIDA.
The Special Populations Office and the AARSWG conducted the 2nd Annual Addiction Research Training Institute on July 21-24, 2009 at Morehouse School of Medicine in Atlanta, Georgia. The ARTI was designed to train early/new investigators to become funded researchers in the area of substance abuse and addiction. The trainees included fourteen post-doctoral fellows and junior faculty members from several academic institutions. Training sessions included presentations on an array of current research findings and opportunities, NIDA/NIH support mechanisms, proposal development and a mock review of trainees' research proposals.
Members of NIDA's Native American/Alaska Native Researchers and Scholars Workgroup convened in Portland, Oregon, during the week of June 8, 2009 to meet and discuss plans for research activities during the upcoming year. A major focus of the workgroup meeting was developing mentoring activities for their "Native to Native Mentoring Program" developed to increase the number of Native Americans and Alaska Natives pursuing research careers in substance abuse research.
Dr. Timothy P. Condon, Deputy Director, NIDA, presented "The Science of Addiction: Implications for Treatment" at the Massachusetts Bureau of Substance Abuse Innovations in Addictions: From Research to Recovery conference in Boston, Massachusetts on May 4, 2009.
Dr. Timothy P. Condon presented "Addiction: It's a Brain Disease Beyond a Reasonable Doubt - The Neuroscience of Addiction" at the Court Services and Offender Supervision Agency for the District of Columbia, in Washington, D.C. on May 7, 2009.
Dr. Timothy P. Condon chaired "Addressing Substance Abuse and Mental Health Needs in Military Personnel and their Families: An Opportunity for Prevention" at the Society for Prevention Research Symposium, in Washington, D.C. on May 27, 2009.
Dr. Timothy P. Condon delivered the open plenary"Effects of Nicotine on the Developing Brain" at the 10th National Synar Workshop - Raising the Bar: Integrating Youth Access Into Comprehensive Tobacco Control, in Phoenix, Arizona on June 9, 2009.
Dr. Timothy P. Condon presented "Treatment is the Key: Addressing Drug Abuse in Criminal Justice Settings" at the National Association of Drug Court Professional's (NADCP) 15th Annual National Drug Court Training Conference, in Anaheim, California on June 11, 2009. He also presented at the opening plenary panel session "20 Years of Getting it Right" on June 12, 2009.
Dr. Timothy P. Condon delivered the keynote presentation "The Young and the Restless: The Role of Adolescent Brain Development in Drug Addiction" at a University of Wisconsin, Madison's Conference, Boys and Girls at Risk: The Emerging Science of Gender Differences - Blending Science with Promising Practices, in Middleton, Wisconsin on June 16, 2009.
Dr. Timothy P. Condon presented "Research on Addiction: What Have We Learned?" at the American Academy of Child & Adolescent Psychiatry (AACAP)-NIDA K12 Program in Reno, Nevada on June 19, 2009.
Dr. Timothy P. Condon presented "Implementing Evidence-Based Practices for Adolescent Treatment" at the Center for Substance Abuse Treatment Satellite Session, Implementing Evidence-Based Practices for Adolescent Treatment, in Sparks, Nevada on June 20, 2009.
Dr. Timothy P. Condon presented "National Institute on Drug Abuse: Progress, Priorities & Plans for the Future" at the 2009 NIDA International Forum, Commonalities Among the Diseases of Addiction: Implications for Treatment and Prevention, in Reno, Nevada on June 20, 2009.
Dr. Timothy P. Condon presented "National Institute on Drug Abuse: Institute Update" at the Addiction Studies Program meeting in Reno Sparks, Nevada on June 20, 2009.
Dr. Timothy P. Condon participated in the Community Anti-Drug Coalitions of America's (CADCA) 1 hour television show entitled "The War Within: Helping Returning Veterans" in St. Petersburg, Florida on July 1, 2009.
Dr. Timothy P. Condon presented "Returning Military Personnel, Veterans & Their Families: How Research is Effecting Positive Change" at the Friends of NIDA Congressional Briefing and Panel Discussion in Washington, D.C. on July 14, 2009.
Dr. Timothy P. Condon presented "The Juvenile Justice System: Identification of the Problems of Alcoholism, Substance Abuse and Related Mental Illness" at the American Bar Association Annual Meeting and Council on Racial and Ethnic Justice symposium, The Juvenile Justice System Youth, Drug & Mental Illness Resources and Policies: Identification of Reforms Needed to Eliminate Discrimination Disparities in Chicago, Illinois on July 30, 2009.
Dr. Timothy P. Condon delivered the plenary presentation "National Institute on Drug Abuse: Institute Update" at the 2009 NIATx Summit and SAAS National Conference in Tucson, Arizona on July 31, 2009.
Dr. Timothy P. Condon presented "On the Cutting Edge: Trends in Alcohol and Drug Abuse and Prevention" and served as a panelist at the 2009 Office of Safe and Drug-Free Schools (OSDFS) National Conference on The Power of Change: Healthy Students, Safe Schools and Engaged Communities, in National Harbor, Maryland on August 3, 2009.
Dr. Timothy P. Condon presented "The Science of Addiction: Implications for Prevention, Treatment and Policy" at the American Sociological Association Annual Meeting, The New Politics of Community, in San Francisco, California on August 9, 2009. He also served as a panelist on the "Science Policy, National Priorities, and Opportunities for the Social Sciences" panel. At the ASA Science Policy breakfast Dr. Condon was honored with the "Science Leader of the Year" award.
Dr. Timothy P. Condon delivered a keynote presentation on "Addiction as a Brain Disease: Implications for Recovery" at the NAADAC, the Association for Addiction Professionals, Sowing the Seeds of Recovery Conference, in Salt Lake City, Utah on August 19, 2009.
Dr. Cindy Miner, Ms. Carol Krause, and Dr. Gaya Dowling, OSPC, presented a workshop entitled "What do teens really want to know about drug and alcohol abuse?" at the National Conference of the Office of Safe and Drug Free Schools on August 3, 2009 in National Harbor, MD.
Dr Susan Weiss, Chief, Science Policy Branch, OSPC conducted a briefing on marijuana for the Office of National Drug Control Policy on April 23, 2009 in Washington DC.
Dr. Susan Weiss presented "NIDA's Screening and Treatment Resources for Medical Health Professionals" at a meeting of the Inter-American Drug Abuse Control Commission (CICAD) on May 7, 2009 in Washington DC.
Dr. Susan Weiss presented "Preventing Drug Abuse and Addiction: What You Need To Know" at the National Association of School Nurses Meeting on June 26, 2009, in Boston, Massachusetts.
Dr. Ruben Baler, Science Policy Branch, OSPC, presented a keynote address entitled "Brain Awareness as Drug Abuse Prevention" at the 2009 Spring Academy on Prevention and Treatment Exchange hosted by the University of Nevada, Reno. (CASAT). May 18-20, 2009, Reno NV.
Dr. Mimi Ghim, Science Policy Branch, OSPC, presented on "Funding Opportunities for Junior Investigators" at the American Psychological Association's Psychology Summer Institute on July 21, 2009.
Dr. Mimi Ghim presented on "NIH Extramural Loan Repayment Programs" at the NIH Loan Repayment Program Session at the Society for Prevention Research Meeting on May 28, 2009.
Dr. Mimi Ghim coordinated the following activities at CPDD, June 20-25, 2009, in Reno/Sparks, NV:  NIDA Tutorials Workshop, chaired by Dr. Ghim, where four NIDA Training Directors presented either their research or a career building/training mini-workshop;  NIDA Training Networking Event, chaired by Dr. Susan Weiss, that provided a forum for training directors, trainees, and NIDA staff to learn about the different training programs that NIDA supports and for trainees to find future training/employment opportunities;  and NIDA Grant Writing Workshop, chaired by Dr. Susan Weiss, that provided information on NIDA Research opportunities, Program interests, review procedures, and grant writing tips to prospective candidates. Topics were presented by Drs. Mimi Ghim, David Shurtleff, Gerald McLaughlin, and Scott Lukas.
Dr. Lula Beatty, Director, Special Populations Office, participated as a planning committee member and faculty at the 2nd annual Leadership Institute for Women in Psychology on August 4, 2009 in Toronto, Canada.
Dr. Lula Beatty, with Dr. LeShawndra Price, DESPR, hosted a roundtable discussion on research grant development at the Quantitative Training for Underrepresented Groups program held at Ryerson University, August 5, 2009 in Toronto, Canada.
Dr. Lula Beatty participated in the annual convention of the American Psychological Association, August 6 – 9, 2009 in Toronto, Canada. She chaired and presented a session titled "Women leading health disparities research for women – career development moves" presented with NIDA grantees, A. Kathy Burlew, Ph.D. and Scyatta Wallace, Ph.D. She hosted roundtable discussions for Division 50 (on health disparities), the Society for the Psychology of Women (on early career development), and the APA Women's Program Office (on federal funding opportunities and strategies).
Dr. Lula Beatty served as a reviewer for the awards program (Carolyn Payton Early Career Award and Graduate Student Research Paper Award) of the Section on the Psychology of Black Women, Society for the Psychology of Women and American Psychological Association in May, 2009 in Washington, D.C.
Dr. Lula Beatty participated in a symposium on health disparities chaired by Rumi Price, Ph.D., at CPDD in June, 2009 in Reno, Nevada.
Dr. Lula Beatty was an invited participant in a plenary session titled "Health and Healing: The Federal Government Initiatives on Reducing Health Disparities" held at the annual meeting of the Association of Black Psychologists, on July 29, 2009 in Atlanta, Georgia.
Dr. Lula Beatty was a presenter in a session titled "Access to Mental Health and Substance Abuse Services: What's Happening in the African American Communities" held at the annual meeting of the Association of Black Psychologists, on July 30, 2009 in Atlanta, Georgia.
Dr. Lula Beatty participated in the Robert Woods Johnson New Connections meeting as a mock reviewer, speed mentor and research grants panelist on June 25 - 26, 2009 in Princeton, New Jersey.
Dr. Lula Beatty participated as a planning committee member and participant in the 2009 4th Annual Connecting Marriage Research to Practice Conference: The Black Family in the 21st Century held June 17-19, 2009 at the University of North Carolina, sponsored by the African American Healthy Marriage Initiative, Administration for Children and Families/HHS.
Ana Anders, M.S.W., SPO, participated in the Hawai'i Addictions Conference and AAPI Workgroup Scientific Conference on May 11-13, 2009 in Honolulu, Hawaii.
Ana Anders was a speaker at the NIH National Hispanic Youth Initiative on July 13, 2009 in Bethesda, Maryland.
Dr. David Shurtleff gave an invited presentation at the Committee on Animal Research and Ethics (CARE) mentoring session entitled: "How to Navigate the NIH" on August 6, 2009 at the annual meeting of the American Psychological Association, Toronto, Canada.
Dr. Jonathan D. Pollock, DBNBR, organized a weekly webinar from January thru July 2009 on the Genetics of Nicotine Addiction, Lung Cancer, and COPD.
Dr. Jonathan D. Pollock chaired the founding meeting of the Consortium for the Genetics of the Analysis of Smoking Phenotypes (CGASP), June 15, 2009. The purpose of the consortium is to conduct a meta-analysis as well as integrate data on the genetics of nicotine addiction, lung cancer, and COPD.
Dr. Jonathan D. Pollock presented a seminar entitled, The NIDA Genetics Program and Important Research Resources" at the Cold Spring Harbor Laboratory, Cellular Biology of Addiction course.
Drs. Cora Lee Wetherington, DBNBR, and Sherry McKee (Yale University School of Medicine) co-organized and co-chaired the symposium, "Role of Sex and Stress in Smoking Maintenance and Relapse," at the annual meeting of the American Psychological Association, August 6-9, 2009 in Toronto, Canada. The panel included: Mariella De Biasi, Ph.D. (Baylor College); Sherry A. McKee, Ph.D. (Yale University School of Medicine) Sudie Back, Ph.D. (Medical University of South Carolina); Mustafa al'Absi, Ph.D. (University of Minnesota Medical School). Rajita Sinha, Ph.D. (Yale University School of Medicine) was the discussant for the presentations.
At the annual meeting of the American Psychological Association (APA), August 6-9, 2009 in Toronto, Canada, Drs. Cora Lee Wetherington and Rajita Sinha (Yale University School of Medicine) were invited by APA's Division on Addiction to serve as co-hosts for the Conversation Hour, "Addiction, Men and Women" chaired by Dr. Nancy Piotrowski, Capella University.
A workshop was organized by Rao Rapaka, DBNBR, entitled, "Fishing for the Hidden Proteome in Health and Disease (drug abuse)at the Hilton Hotel, Rockville, Bethesda MD, May 21-22, 2009.
A workshop on "Chemical Genomics", July 17-18, Portland, Oregon, Benson Hotel was organized by Rao Rapaka as a satellite meeting to the International Narcotic Research Conference's (INRC) Annual Meeting.
Dr. Vishnu Purohit co-chaired and co-organized a NIH STEP symposium on Mind-Body Medicine – Fact or Fiction, Bethesda, Maryland, May 7, 2009. The following areas were presented by four speakers: Overview of the Science (Dr. Esther Sternberg, NIMH/NIH); Science of Meditation and Health (Dr. Frederick Hecht, University of California at SF); Science of Biofeedback (Dr. Lynda Thompson, Biofeedback Institute of Toronto, Canada); and Traditional Taiji and Qigong (Dr. Yang Yang, University of Illinois at Champaign-Urbana). Dr. Page McDonald, NCI, and Dr. Deborah Hayes, NCCAM, were discussants for the symposium.
Dr. Roger Sorensen, DBNBR, represented NIDA and the NIH at the 2009 NIH Regional Seminars on Program Funding and Grants Administration held on April 16 - 17, 2009 in Atlanta, GA, co-hosted by Georgia State University and the Georgia Institute of Technology; and on June 25 - 26, 2009 in Las Vegas, NV, co-hosted by the University of Nevada, Las Vegas and the University of Nevada, Reno. The Regional Seminar program provides institution administrators and scientific investigators with an inside look at processes and policies at the NIH. He gave two presentations; "Grant Writing for Success", and "Working with NIH Program Officials: PreAward & PostAward", as well as providing insight into the NIH granting process.
Dr. Nancy Pilotte, DBNBR, chaired a session entitled "Response to Social Stress Predicts Vulnerability to Drug Abuse" at the American Psychiatric Association Annual Meeting on May 19, 2009, in San Francisco, CA.
Drs. Nancy Pilotte and Jerry Frankenheim, DBNBR, co-chaired entitled "Hot Topics at NIDA" at the INRC Annual Meeting on July 15, 2009, in Portland, OR.
Dr. Allison Hoffman, DBNBR, with many colleagues from NIDA, served on the planning committee for the National Hispanic Science Network Annual Meeting, held October 29-31, 2009, Miami, FL.
Dr. Allison Hoffman with Lucinda Miner, OSPC, served on the planning committee for the 2nd Menthol Conference, held Oct 19-20, 2009, Atlanta, GA.
Dr. Samia Noursi presented a poster at NIDA's International Forum at the College on Problems of Drug Dependence (CPDD), June 20-25, 2009 in Reno/Sparks, Nevada. The poster described NIDA's Women and Sex/Gender Differences Research Program: program history, goals, and research interests.
Dr. Wilson Compton, Director, DESPR, and Dr. Meyer Glantz, DESPR co-chaired a symposium titled, "Spotting the Wolf in Sheep's Clothing: Clinical Challenges Identifying and Treating Unpresented Comorbidity" at the American Psychiatric Association Meeting held in San Francisco, California, May 18, 2009. The presentations and discussion focused on psychiatric patients presenting for mental health treatment who have concurrent substance abuse disorders (SUD) which go unidentified and untreated.
Dr. Wilson Compton and Moira O'Brien, DESPR, co-chaired a workshop on, "The Diversion of Prescription Stimulants," for the American Psychiatric Association Meeting held in San Francisco, California, May 18, 2009.
Dr. Wilson M. Compton presented on implementation science and on the epidemiology of comorbid drug abuse and PTSD at the annual meeting of the American Society of Addiction Medicine, New Orleans, Louisiana, May 1-3, 2009.
Dr. Wilson M. Compton presented two lectures on epidemiology and neuroscience at Transylvania University, Lexington, Kentucky, May 5, 2009.
Dr. Wilson M. Compton participated in and presented at the American Psychiatric Association's annual meeting, San Francisco, California, May 26-28, 2009.
Dr. Wilson M. Compton participated in the Society for Prevention Research annual meeting, Washington, D.C., May 26-28, 2009.
Dr. Wilson M. Compton presented to the Boston Federal Re-entry Court, Boston, Massachusetts, June 16, 2009.
Dr. Wilson M. Compton presented at the annual meeting of the College on Problems of Drug Dependence, Reno, Nevada, June 25, 2009.
Dr. Wilson M. Compton participated in the ONDCP Inter-agency Workgroup for Demand Reduction, meetings have been held on an ongoing basis since March 2009.
Dr. Wilson M. Compton presented a keynote address to the National Youth Leadership Forum-Medicine, College Park, Maryland, July 6, 2009.
Drs. Redonna Chandler and Dionne Jones, DESPR, co-presented a New Investigators' Workshop via Adobe Connect for faculty and graduate students at the University of South Florida, June 15, 2009.
Dr. Elizabeth Ginexi, PRB, DESPR served as Co-Chair along with Dr. Michael Bardo of the University of Kentucky on an invited Paper Symposium at the annual meeting for the Society for Prevention Research in Washington, DC on May 27, 2009 titled "Neural and Behavioral Mechanisms of Inhibitory Control: Implications for Drug Abuse Prevention." Dr. David Jentsch of UCLA, Dr. Mark Fillmore of University of Kentucky, Dr. Carl Lejuez of University of Maryland presented papers, and Dr. Donald Lynam of Purdue University served as the discussant.
Dr. Elizabeth Ginexi served as the discussant for a Paper Symposium at the annual meeting for the Society for Prevention Research in Washington, DC on May 28, 2009 titled "Methods of Examining Peer and Social Networks in Prevention Research." Drs. Paul Juarez of Meharry Medical College, Michael Mason of Villanova University, and Isabella Lanza of Temple University presented papers.
Dr. Elizabeth Ginexi served as the discussant for a Paper Symposium at the annual meeting for the Society for Prevention Research in Washington, DC on May 29, 2009 titled "One Size Does Not Fit All: The Next Generation in Drug Prevention Communications Research." Drs. William Crano of Claremont Graduate University, William Shadel of RAND Corporation, and Rick Zimmerman of the University of Kentucky presented papers.
Dr. Elizabeth Ginexi served as Co-Chair along with Dr. Amy Goldstein, NIMH on a Paper Symposium at the annual meeting for the Society for Prevention Research in Washington, DC on May 29, 2009 titled "Methods in Longitudinal Prevention Research: Who, What, When." Drs. David MacKinnon of Arizona State University, Getachew Dagne of the University of South Florida, Hanno Petras of Johns Hopkins University, and Elizabeth Stuart of Johns Hopkins University presented papers.
Dr. Jacqueline Lloyd, PRB, DESPR, organized and chaired a symposium titled "The Role of Social Networks in HIV and STI Transmission Risk and Prevention in High Risk Drug Using Populations" at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009. The symposium discussant was
Dr. Richard Jenkins and the presenters were Drs. Carl Latkin of Johns Hopkins Bloomberg School of Public Health, Jianghong Li of the Institute for Community Research, and Thomas Valente of the Keck School of Medicine, University of Southern California.
Drs. Jacqueline Lloyd and Eve Reider of PRB, DESPR co-moderated a plenary roundtable session titled "Sexual Health and Risk Reduction: Theory to Practice" at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009. The presenters were Dr. John Delamater of the University of Wisconsin, Dr. Janet S. St. Lawrence of Mississippi State University, and Kevin Cranston of the Massachusetts Department of Public Health.
Dr. Aleta Meyer, PRB, DESPR, organized and chaired a paper symposium titled "Utilizing Bidirectional Paths of Influence between Consumers, Practitioners, and Researchers to Design Prevention Strategies" at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009. The symposium discussant was Dr. Abraham Wandersman from the University of South Carolina. The presenters were Dr. Margaret Weeks of the Institute for Community Research, Dr. Jerry Schultz of Kansas University, and Ms. Amy Syvertsen of the Pennsylvania State University.
Dr. Aleta Meyer served as Co-Chair along with Dr. LeShawndra Price, ERB, DESPR, for a paper symposium at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009 titled "Problematic Relationships as Shared Risk Factors for Adolescent Dating Violence and Substance Use." The symposium discussant was Dr. David Wolfe. The presenters were Dr. Luz McNaughton Reyes of the University of North Carolina-Chapel Hill, Dr. Terri Sullivan of Virginia Commonwealth University, and Dr. Debra Capaldi of the Oregon Social Learning Center.
Dr. Aleta Meyer organized and chaired a paper symposium titled "Working Relationships with Cooperative Extension: A Gold Mine for Translating Science into Practice at the National Level" at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009. The symposium discussant was Dr. Suzanne LeMenestrel, National Leader for Youth Development Research at Cooperative State Research, Education, and Extension Service (USDA). The presenters were Dr. Louise Parker of Washington State University, Dr. Richard Spoth of Iowa State University, and Mr. Brian Bumbarger of the Pennsylvania State University.
Dr. Eve Reider represented NIDA on June 2, 2009 at meeting entitled "U.S. Army Suicide Reduction and Prevention Research," held by the Military Operational Medicine Research Program (MOMRP), U.S. Army Medical Research and Materiel Command (USAMRMC).
Dr. Eve Reider was a member of the program planning committee for the 17th Annual Society for Prevention Research Annual Meeting that was held May 26-29, 2009 in Washington, DC.
Dr. Eve Reider was an organizer and theme reviewer for the 2nd Annual NIDA International Poster Session, held May 26, 2009 at the 17th Annual Society for Prevention Research Annual Meeting, Washington, DC.
Dr. Eve Reider organized an invited symposium for NIDA at the 17th Annual Meeting of the Society for Prevention Research. The symposium was co-chaired by
Dr. Timothy Condon, Deputy Director, NIDA, and Dr. Joan Hall, Senior Program Manager, U.S. Army Military Operational Medicine Research Program. The symposium was entitled Addressing Substance Abuse and Mental Health Needs in Military Personnel and their Families: An Opportunity for Prevention. Presenters were Christopher Spera, Ph.D., ICF International, Richard E. Heyman, The Research Foundation of State University of New York Stony Brook, and Richard Keller, R.N., U.S. Army Battlemind Program Walter Reed Army Institute of Research. The discussion was led by Michael Kilpatrick, M.D., Director of Strategic Communications Military Health System, Office of the Assistant Secretary of Defense for Health Affairs. The symposium was held May 27, 2009 in Washington, D.C.
Dr. Eve Reider served as moderator and discussant for the Paper Symposium "The Protective Effects of Parent-Adolescent Communication Against Substance Abuse" which was held May 29th, 2009 at the 17th Annual Meeting for the Society for Prevention Research in Washington D.C. Presenters included Nikola Zaharakis, B.A., Virginia Commonwealth University, Kate Ralston, Ph.D., Iowa State University, and Peggy S. Meszaros, Ph.D., Virginia Tech.
Drs. Belinda Sims and Aria Crump, DESPR, organized an NIH Update Session at the Society for Prevention Research Meeting in Washington DC on Thursday, May 28, 2009.
Drs. Belinda Sims and Elizabeth Robertson, DESPR, co-chaired a research roundtable titled, "Advancing Prevention Research at the National Institute on Drug Abuse" at the annual meeting of the Society for Prevention Research on Thursday, May 28, 2009. The discussants were Irwin Sandler, Anthony Biglan, Mark Greenberg, Eve Reider (NIDA/DESPR), Mary Jane Rotheram-Borus, and Zili Sloboda.
Dr. Belinda Sims chaired a symposium titled, "Intervening with High Risk Youth and Young Adults in Service Settings and Systems" at the annual meeting of the Society for Prevention Research on Friday, May 29, 2009. The presenters were Dr. Janet Kilian, Touro College Graduate School of Psychology, and Dr. Benjamin VanVoorhees, University of Chicago (presented by Patrick DeGregorio).
Dr. Richard Jenkins, DESPR, gave a plenary presentation titled, "Applied Roles and the Future of Community Psychology" at the Biennial Meeting of the Society for Community Research and Action in Montclair, NJ, June 18 – June 21, 2009.
Dr. Richard Jenkins facilitated a mentoring session titled, "Opportunities for Funding and Employment in the Federal Government" at the Biennial Meeting of the Society for Community Research and Action in Montclair, NJ, June 18 – June 21, 2009.
Drs. Richard Jenkins, Jacqueline Lloyd and Eve Reider, DESPR, chaired and co-organized a plenary session titled "Sexual Health and Risk Reduction: Theory to Practice" at the Society for Prevention Research Annual Meeting in Washington D.C., May 26 – May 29, 2009. The presenters were John Delamater, Janet St. Lawrence, and Kevin Cranston.
Dr. Richard Jenkins served as the discussant for a panel on "Advanced Statistical Modeling of Risk Behavior Over Time" at the annual meeting of the Society for Prevention Research in San Francisco, May 28-30, 2009. Panelists included Ed Smith, Donna Coffman, Megan Patrick, and Stephanie Lanza, all from Pennsylvania State University.
On March 5 and 6, 2009, Dr. LeShawndra Price, DESPR, presented "NIDA Initiatives, Collaborations, and Research Activities" at the U.S. State Department Meeting Promoting Resiliency & Protecting Children from the Psychological Consequences of Violence: Recent Findings and Future Directions.
On May 22, 2009, Dr. LeShawndra Price, DESPR, served as a panelist for a Workshop entitled, "Show Me the Money: Grant-Getting for Graduate Students and New Faculty" at the annual meeting of the Association for Psychological Science in San Francisco, CA.
On May 27, 2009, Drs. Aleta Meyer and LeShawndra Price of DESPR co-chaired a paper symposium at the Society for Prevention Research annual meeting in Washington, DC entitled, "Problematic Relationships as Shared Risk Factors for Adolescent Dating Violence and Substance Use." Drs. Deborah Capaldi of the Oregon Social Learning Center, Luz Reyes of the University of North Carolina at Chapel Hill, and Terri Sullivan of the Virginia Commonwealth University presented papers. Dr. David Wolfe of the University of Toronto served as discussant.
Dr. Naimah Weinberg, DESPR, chaired a symposium entitled "The Genes, Environment, and Development Initiative (GEDI) of the Minnesota Center for Twin and Family Research" at the annual meeting of the Behavior Genetics Association in Minneapolis, MN, on June 19, 2009.
Dr. Dionne Jones, DESPR, presented on "Funding Opportunities through NIDA/NIH" and served as faculty/mentor in NIDA's Addiction Research Training Institute held in Atlanta, GA, July 20-24. 2009.
Dr. Dionne Junes organized and chaired a symposium, "Making Health Care and Treatment Services Work for Abused Women" at the American Psychological Association Annual Meeting, August 6-9, 2009, Toronto, Canada.
Dr. James Bjork attended the Annual Meeting of the Organization for Human Brain Mapping in San Francisco on June 22, 2009, where he gave a presentation entitled Changes in NIH Peer Review: Implications for Neuroimaging.
Dr. James Bjork attended the Annual Meeting of American Psychiatric Association in San Francisco on May 20, 2009, where he gave a presentation entitled Rewards, Risk, and the Teenage Brain: Insights from functional MRI as part of a workshop entitled "Teen Risk-Taking: Translating Neuroscience Into Real Life Choices."
Dr. Joseph Frascella, Director, DCNBR, participated in the 2009 NIDA International Forum and gave a presentation ("Common Brain Mechanisms in Addiction and Obesity"). This meeting was a satellite to the Annual CPDD meeting in Reno, NV on June 20, 2009.
Dr. Joseph Frascella, DCNBR participated in the CPDD "Brunch with Champions" session at the annual meeting of the College and spoke with junior investigators about their research and career plans in Reno, NV on June 25, 2009.
Dr. Nicolette Borek, DCNBR, attended the Pediatric Academic Societies (PAS) annual meetings in Baltimore, MD held May 2-5, 2009. The PAS Annual Meeting is a unique forum for pediatrics which provides an opportunity for representatives from almost all pediatric subspecialty areas to collaborate, exchange findings and share ideas that propel the future of child health. The PAS is comprised of four sponsoring organizations–the American Pediatric Society, the Society for Pediatric Research, the Academic Pediatric Association and the American Academy of Pediatrics.
Dr. Cheryl Anne Boyce, DCNBR, attended the Clinical Translational Science Awards (CTSA) CTSA Consortium Child Health Oversight Committee (CC-CHOC) Face-to-Face Meeting, in conjunction with the PAS Meetings on May 1, 2009. The CC-CHOC is the national forum for CTSA investigators and NIH scientists to identify collaborative opportunities to facilitate child health clinical and translational research through the CTSA program.
Dr. Nicolette Borek, DCNBR, was a co-organizer and participant for the Consultation on the Inclusion of Adolescents in HIV Prevention Clinical Trials which was held on June 18 and 19, 2009 in Washington, DC. The meeting was sponsored by NIDA, NICHD, NIMH, NIAID, and the Forum for Collaborative HIV Research and brought together staff from NIH and FDA, domestic and international experts from academia, industry, HIV-affected communities, Foundations, Advocacy groups and the WHO to discuss adolescents' participation in biomedical HIV prevention trials including microbicides, PrEP, and HIV vaccine trials.
Dr. Cheryl Anne Boyce, DCNBR attended the Society for Neuroscience first sponsored summit meeting entitled, "Neuroscience Research in Education Summit" held at the Center for the Neurobiology of Learning and Memory at UC Irvine on June 22 to 23, 2009. The meeting was held to encourage and catalyze dialogue between educators and scientists to positively influence pre-K–12 student development and learning. Participants included leaders in neuroscience and education, including researchers, practitioners, and policymakers, as well as representatives of foundations, associations, and the media.
At the invitation of the Psychiatry and Behavioral Sciences section, Dr. Cheryl Anne Boyce participated as an expert speaker for the educational program presented on "Transformative Neurodevelopmental Research Priorities and the NIDA Strategic Plan" at the 2009 National Medical Association convention in Las Vegas, NV.
At the 2009 American Psychological Association (APA) Convention in Toronto, Canada, Dr. Cheryl Anne Boyce presented at various grant workshop and scientific sessions. She chaired an invited plenary by NIH grantee Dr. Dante Cichetti on "Developmental Psychopathology in Action: Nature, Nurture, and Change." She presented on DCNBR divisional priorities in the session, "Navigating Change at NIH/NIDA---Exciting Opportunities in Tight Times" chaired by Kristen Huntley (DEA) and with fellow NIDA presenters David Shurtleff (DBNBR), Belinda Sims (DESPR) and Harold Perl (CTN). She highlighted NIDA and NIH funding initiatives in her presentation "Financial Support Opportunities for Minority Students" at a graduate student symposium. For the presentation which described the community based participatory research project the AAKOMA project, she served as a discussant to highlight the important role of the community and recent NIH initiatives in this area. Finally, as a speaker for a symposium focused on the measurement of stress and trauma, she presented on "Youth Stress and Trauma Measurement Across Multiple Levels of Analysis" to review models integrating clinical neuroscience, behavioral and sociocultural considerations.
Dr. Lisa Onken, DCNBR, with representatives from multiple ICs, including NIMH, NIA, and NIAAA, co-organized a trans-NIH Roadmap meeting on the Science of Behavior Change that took place on June 15-16, 2008 in Bethesda, Maryland. Dr. Onken moderated the panel on "Changing Existing Behaviors."
Dr. Lisa Onken assisted in planning a meeting led by Dr. Melissa Riddle of NIDCR. The meeting, "Behavioral Intervention Research at a Crossroads: Where Do We Go From Here?" took place at NIDCR on July 23-24, 2009 in Bethesda, Maryland. Dr. Onken moderated a panel called "Starting Points for Intervention Development Research."
Dr. Lisa Onken helped to plan a planning meeting for the Advanced Training Institute on Health Behavior at the National Cancer Institute on July 28-29, 2009. In addition, Dr. Onken presented NIDA's research portfolio on theoretically-drive intervention research.
On April 26, 2009, Dr. David McCann, Acting Director, DMPCDA, chaired the "NIDA Medications Development Workshop: Smoking Cessation and Beyond" as a satellite to the annual meeting of the Society for Research on Nicotine and Tobacco in Dublin, Ireland. The workshop entailed a presentation by Dr. Elbert Glover, University of Maryland, entitled Evaluation of Selegiline Transdermal System for Smoking Cessation: Preliminary Results of NIDA's 246 Subject, Multi-Site Trial, a presentation by Dr. Celia Jaffe Winchell (FDA) entitled Medications to Treat Tobacco Dependence: An FDA Perspective, and presentation by Dr. McCann entitled Medications Development for Polydrug Addiction Treatment: A NIDA Perspective.
Dr. Ivan Montoya, DPMCDA, led the workshop entitled: "Funding Opportunities at NIH" at the Latino Mental Health Conference in New Brunswick, New Jersey on June 11-13, 2009.
Dr. Ivan Montoya gave the lecture entitled "Treatment Update: What Works/What's Ready? Pharmacotherapies" at the NASADAD meeting in Syracuse, New York on June 3, 2009.
Dr. Ivan Montoya chaired the symposium entitled "The New World of Naltrexone: New Formulations, New Indications" at the NIDA International Satellite Conference, in Reno, Nevada on June 20, 2009. It included presentations by Dick Hawks (History and Pharmacology of Naltrexone), Sandra Comer (New formulations of naltrexone in the U.S.A.), Evgeny Krupitsky (Evaluation of new formulations of naltrexone for opioid dependence in Russia), David Gastfriend (Naltrexone for alcohol dependence around the world) and Johan Franck (Naltrexone for methamphetamine addiction in Scandinavia). The discussant was Chuck O'Brien.
Dr. Ivan Montoya gave an oral presentation entitled "Impact of inclusion and exclusion criteria on clinical trials of drug abuse pharmacotherapies" at the symposium entitled: "From clinical trials to practice: The implications of inclusion and exclusion criteria in clinical trials of pharmacotherapies to treat drug dependence", at the CPDD meeting in Reno (NV), on June 25, 2009.
Dr. Jag Khalsa, DPMCDA, presented/participated in the Annual Meeting of the American Society of Addiction Medicine (ASAM), New Orleans, April 2009. He chaired three symposia: "Substance Abuse Associated Comorbidity", covering the physiological and biochemical systems impacted by drug abuse and infections; (2) "Medical Marijuana: Revisited", where panelists discussed the current status of medical marijuana research; (3) "International Collaborations Between ASAM and ISAM: Unique Treatment Models for Substance Abuse", where speakers from Iceland (Dr. Tyrfingsson), Russia (Dr. Krupitsky), and UK (Dr. Strang) presented drug addiction treatment programs in their respective countries.
Dr. Jag Khalsa attended the Annual Meeting of the American Association for the Oro-maxillary Surgeons (AAOM), Chicago, IL, May 2009, and encouraged the members to conduct research on oromaxillary/dental consequences of drug addiction.
Dr. Jag Khalsa participated in the Annual Meeting of the ACTHIV (American Conference on Treatment of HIV Treatment) in Denver, CO), May 2009.
Dr. Jag Khalsa gave an invited lecture at the Inauguration of a newly established Institute of NeuroImmune Pharmacology at the Florida International University, Miami, June 1, 2009, and also attended the 9th International Conference on NeuroVirology (ICNV), Miami, June 2-3, 2009.
Dr. Jane B. Acri, DPMCDA, participated in a workshop entitled "Evaluating the Abuse Potential of Novel Compounds and Abuse Resistant Formulations," at the College on Problems of Drug Dependence. The workshop was chaired by Michael A. Nader, and Dr. Acri's presentation was entitled, "The role of NIDA in the evaluation of emerging drugs of abuse." Her presentation described data generated by NIDA on emerging drugs of abuse as identified by the DEA.
Dr. Petra Jacobs, CCTN, chaired a pre-conference session at the American Association for the Treatment of Opioid Dependence (AATOD) meeting on April 26, 2009 in New York, NY. This session provided an overview of new research findings addressing opioid analgesic dependence including assessment, co-occurring pain, patient characteristics, and treatment approaches.
The 30th Annual Meeting of the Society for Clinical Trials took place May 3-6, 2009, in Atlanta, GA. CCTN staff participated in the following sessions.
1) Dr. Paul Wakim organized and chaired an invited session titled, "Is a Null Result a Failure? Can Anything Good Come out of Null Results?"
2) Joint work by Ms. Carmen Rosa and Dr. Paul Wakim on "Participation in Substance Abuse Clinical Trials: Comparing Gender and Racial/Ethnic Groups" was presented as part of a Contributed Paper Session titled, "Patient Recruitment, Enrollment and Retention".
Dr. Betty Tai, Director, CCTN, co-chaired a symposium on "International and Global Issues in Drug Abuse Treatment" at the NIDA 2009 Hawaii Addictions Conference/AAPI Workgroup Scientific Conference on Addiction and Related Issues: Focusing on Recent Research and Culturally Relevant Treatments Among Asian Americans and Pacific Islanders, May 11-12, 2009 Honolulu, Hawaii.
Dr. Udi E. Ghitza, CCTN, co-chaired a NIDA-sponsored symposium entitled Integrating Treatment for Substance Use and Post-Traumatic Stress Disorders in Patients with Co-occurring Conditions at the American Psychiatric Association Annual Meeting in San Francisco, CA, May 16-21, 2009. The purpose of this symposium was to examine the challenges and opportunities for advancing an integrated medical care approach concurrently treating functional impairments associated with both substance use and post-traumatic stress disorders in patients with co-occurring conditions.
The Regional Dissemination Workshop Series promotes and encourages adoption and implementation of the CTN products. The Oregon/Hawaii and Pacific Northwest Nodes with the Northwest Frontier Addiction Technology Transfer Center and the CCTN hosted the first CTN Regional Dissemination Workshop June 3-4, 2009 in Portland, Oregon. The workshop highlighted treatment products tested in the clinical trials conducted by the CTN. There were 135 registered participants. The workshop featured speakers from the CTN and ATTC Networks. Dr. Betty Tai delivered the plenary presentation. Dr. Harold Perl and Ms. Michele Straus also attended.
Dr. Petra Jacobs and Dr. Richard Denisco (DESPR) co-chaired the NIDA/Prescription Opioid and Pain Workgroup–sponsored workshop entitled "Opioid Agonist Medications Effects on Cardiovascular System." This workshop was held on June 16, 2009 in Rockville, MD.
Dr. Mary Ellen Michel, CCTN, presented an overview of the CCTN's research to representatives from other NIDA divisions, NIMH and the CDC. The meeting was organized by NIDA's Office of AIDS Research on June 24, 2009.
The College on Problems of Drug Dependence (CPDD) held its 71st annual meeting June 20-25, 2009, in Reno/Sparks, Nevada. CCTN staff participated in the following:
- Dr. Raul Mandler chaired a mini symposium entitled, "HIV Risk Prevention in the CTN." Dr. Susan Tross, Chief of the CTN-HIV-SIG from the CTN LI Node, Dr. Donald Calsyn, from the Pacific Node and Dr. Lisa Metsch from the FL Node discussed Comparative Effectiveness Research of HIV Prevention Protocols done in the CTN, focusing of gender and minority differences.
- A poster presentation by Ms. Carmen Rosa and Dr. Paul Wakim on "Participation in Substance Abuse Clinical Trials: Comparing Gender and Racial/Ethnic Groups" was presented on June 25, 2009.
- A poster presentation by Drs. Steven Sparenborg, Udi Ghitza, and Betty Tai on "Comparative effectiveness research in the National Drug Abuse Treatment Clinical Trials Network (CTN)" was presented on June 25, 2009.
Drs. Udi E. Ghitza, Steven Sparenborg, Betty Tai, and Ms. Michele Straus, organized a NIDA-sponsored two-day meeting entitled, "Narrowing the Research-Practice Divide in Evidence-Based Medicine with Adoption of Electronic Health Record Systems: Present and Future Directions" on July 13-14, 2009 in Rockville, MD. The purpose of the meeting was to explore the prospects and challenges of using electronic health record systems to bridge the gap between specialized substance abuse treatment and mainstream medical care.
Drs. Michelle Leff and Betty Tai organized a health Economics workshop on July 30-31, 2009. There were four specific goals for this workshop: 1) Raise awareness of the feasibility and potential value of economic evaluation in addiction treatment clinical trials. 2) Address design issues to improve the feasibility of these studies, such as a standard inventory of cost analysis measures to integrate into addiction treatment RCTs. 3) Address the perspectives of the various stakeholders and identify meaningful metrics for communicating results. 4) Develop a white paper with recommendations from this workshop to serve as initial guidance for future CTN trials.
Ms. Carmen Rosa attended the 2009 21st Annual Native Health Research Conference in Portland, OR, August 3-6. During the conference, she visited the Suquamish tribe in Washington on August 3. She also conducted site visits to two of the CTN study sites, the Native American Rehabilitation Association (NARA), in Portland, and the Warm Springs reservation in Oregon, August 5-6, 2009.
NIDA CCTN staff participated in the 117th Annual Convention of the American Psychological Association Meeting, held August 6-9, 2009 in Toronto, Canada as follows:
- On August 5, 2009, Dr. Harold Perl taught a half-day workshop (with Dr. Kristen Huntley of OSA) as a pre-convention workshop titled, "Unlock the Mysteries of NIH Funding: Improve Your Application and Improve Your Chances at Success."
- On August 6, 2009, Dr. Perl gave a talk titled, "What Really Matters in Turning Evidence into Impact? NIDA Programs to Advance Drug Abuse Treatment Practice," as part of a symposium session titled, "Evidence Based Practices: What Do We Mean By Evidence?"
- On August 7, 2009, Dr. Perl gave a talk titled, "Exciting Opportunities in Tight Times: Grant Mechanisms and Academic/Business Partnerships," as part of a symposium session titled, "Navigating Change at NIH/NIDA: Exciting Opportunities in Tight Times."
Dr. Teresa Levitin, Director, OEA, co-organized a workshop for the annual meeting of the American Sociological Association on funding opportunities at NIDA and presented a paper at that session on changes in review policies and procedures at NIH and NIDA.
Dr. Jose Ruiz, OEA, co-organized and moderated the "Career Development Workshop" at CPDD, June 2009.
Dr. Gerald McLaughlin, OEA, co-organized and co-presented at three workshops: "What's New at NIDA and NIH", "Career Development" and "Grant Writing" at the June 2009 CPDD meeting.
Dr. Kristen Huntley, OEA, organized and chaired a symposium titled "Navigating Change at NIH/NIDA: Exciting Opportunities in Tight Times" and presented "Policy Updates and Changes in Peer Review" at the American Psychological Association 117th Convention, Toronto, August 2009.
Dr. Scott Chen, OEA, was a judge for medical student research posters at Georgetown University School of Medicine's 23rd Annual Student Research Days Competition and Exposition 2009.
Dr. Gerald McLaughlin, OEA, was a judge at the graduate student research competition of the Georgetown University School of Medicine, June, 2009.
Dr. Nadine Rogers, OEA, presented "De-Mystifying NIH Grants Review" at the Mini Medical School & Summer Research Training Institute at Morehouse School of Medicine, Atlanta, GA, July 22, 2009.
Dr. Jose Ruiz, OEA, was a speaker at the "What's New at NIDA" Symposium at CPDD, June 2009.
Dr. Kristen Huntley co-chaired a Pre-Meeting Workshop titled "Unlock the Mysteries of NIH Research Funding-Improve Your Grant Application and Improve Your Chance at Success" at the American Psychological Association 117th Convention, Toronto, August 2009.
Dr. Kristen Huntley was a planning committee liaison to three Institutes for the Office of Behavioral and Social Science Research Capitol Hill Poster Session: "National Institutes of Health: Improving the Nation's Health through Behavioral and Social Sciences Research", April 28, 2009.
Dr. Scott Chen was a co-organizer and co-presenter at the "What's New at NIDA" symposium at the 2009 CPDD Annual Meeting.
Dr. Amy Newman, IRP, was invited to give a seminar entitled "Molecular Tools to Study Drug Addiction" at the Center for Drug Discovery's "7th Annual Current Trends in Drug Abuse Research" Northeastern University, Boston MA, May 2009.
Jonathan Katz, IRP, was invited to give a talk entitled: "Behavioral Pharmacology of Atypical Dopamine Uptake Inhibitors: Potential for Understanding the Dopamine Transporter and as Treatments for Stimulant Abuse" to the Department of Pharmacology, Drexel University College of Medicine, January 2009.